GlycoMimetics Inc. (GLYC)
NASDAQ: GLYC
· Real-Time Price · USD
0.20
0.00 (0.70%)
At close: Jun 06, 2025, 3:37 PM
0.70% (1D)
| Bid | 0.2 |
| Market Cap | 12.7M |
| Revenue (ttm) | 54.09K |
| Net Income (ttm) | -29.49M |
| EPS (ttm) | -0.46 |
| PE Ratio (ttm) | -0.43 |
| Forward PE | -6.97 |
| Analyst | n/a |
| Ask | 0.2 |
| Volume | 57,715,268 |
| Avg. Volume (20D) | 753,607 |
| Open | 0.21 |
| Previous Close | 0.20 |
| Day's Range | 0.18 - 0.21 |
| 52-Week Range | 0.14 - 0.63 |
| Beta | 1.60 |
About GLYC
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GLYC
Website n/a
Just now
-5.43%
GlycoMimetics shares are trading higher after the ...
Unlock content with
Pro Subscription
7 months ago
+191.32%
GlycoMimetics shares are trading higher after the company announced it will merge with Crescent Biopharma and secured $200 in funding to advance its oncology pipeline.
